Sun Pharmaceutical Industries Limited
SUNPHARMA
Clasificación en acciones
#520
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
Precio por acción
$19.24
Última sincronización: 2026-10-19
Capitalización bursátil
$46.15B
Cambio (1 día)
-0.97%
Cambio (1 año)
0.11%
País
IN
Comercio Sun Pharmaceutical Industries Limited (SUNPHARMA)
Categoría
Healthcare
Ratio P/S de Sun Pharmaceutical Industries Limited (SUNPHARMA)
Ratio P/S al October 2026 TTM: 7.06
Según los informes financieros más recientes y el precio de las acciones de Sun Pharmaceutical Industries Limited, el ratio P/S actual (TTM) es 7.06. Al final de 2024, el ratio P/S era 8.06.
Historial del ratio P/S de Sun Pharmaceutical Industries Limited desde 2004 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| 2026 (TTM) | 7.06 | -8.81% |
| 2025 | 7.74 | -3.96% |
| 2024 | 8.06 | 49.97% |
| 2023 | 5.37 | -5.34% |
| 2022 | 5.68 | 32.61% |
| 2021 | 4.28 | 66.34% |
| 2020 | 2.57 | -34.88% |
| 2019 | 3.95 | -14.31% |
| 2018 | 4.61 | -12.68% |
| 2017 | 5.28 | -24.75% |
| 2016 | 7.02 | -21.91% |
| 2015 | 8.99 | 21.43% |
| 2014 | 7.40 | -0.77% |
| 2013 | 7.46 | 1.13% |
| 2012 | 7.38 | -7.90% |
| 2011 | 8.01 | -15.75% |
| 2010 | 9.51 | 76.44% |
| 2009 | 5.39 | -26.13% |
| 2008 | 7.29 | -21.66% |
| 2007 | 9.31 | -4.42% |
| 2006 | 9.74 | 34.88% |
| 2005 | 7.22 | 17.66% |
| 2004 | 6.14 | 0.00% |
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| - | - |
CN
|
